Human Mutation · 2022 · 10 citations · 12 references
Life SciencesGeneticsMolecular GeneticsCancer GeneticsHuman GeneticsMedical GeneticsGenetic DisordersGermline Cancer PredispositionGermline Cancer SusceptibilityHereditary Cancer SyndromesOncogenic Signaling PathwaysRas Family OncogenesCancer Susceptibility SyndromesGenetic Predisposition To CancerGermline Cancer Predisposition SyndromesGermline MutationsMapk Pathway MutationsMitogen-activated Protein Kinase PathwaysRas-mitogen-activated Protein Kinase SignalingSomatic Mutations
RASopathies are disorders caused by germline mutations in genes that encode components of the RAS/mitogen-activated protein kinase (MAPK) pathway. These syndromes share features of developmental delay, facial dysmorphisms, and defects in various organs, as well as cancer predisposition. Somatic mutations of the same pathway are one of the primary causes of cancer. It is thought that germline cancer-causing mutations would be embryonic lethal, as a more severe phenotype was shown in Drosophila and zebrafish embryos with cancer MAP2K1 mutations than in those with RASopathy mutations. Here we report the case of a patient with RASopathy caused by a cancer-associated MAP2K1 p.Phe53Leu mutation. The postzygotic mosaic nature of this mutation could explain the patient's survival.
12
Diverse Biochemical Properties of Shp2 Mutants
Heike Keilhack, Frank David, Malcolm J. McGregor et al. · Journal of Biological Chemistry · 2005 · 311 citations · Full text